Waldencast plc Class A Ordinary Share (WALD)
Waldencast plc is a global beauty and wellness company focused on acquiring, building, and growing prestige brands. It emphasizes innovative and consumer-centric products within the skincare, haircare, and fragrance segments, aiming to establish a diverse portfolio of leading brands through strategic acquisitions and development.
Company News
Obagi Medical introduces a new scalp serum clinically proven to reduce hair loss and promote fuller hair, targeting individuals experiencing hair thinning through a scientifically formulated product.
Waldencast has acquired Novaestiq Corp. and the U.S. rights to the Saypha® injectable hyaluronic acid gel line, expanding Obagi Medical's portfolio into dermal fillers and positioning the company at the intersection of skincare and aesthetic treatments.
The consensus price target hints at a 26% upside potential for Waldencast PLC (WALD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.